NCT06951594

Brief Summary

Robotics-assisted electrode insertion overcomes many surgeon-related kinetic limitations such as insertion speed, tremor, drift, and lack of accurate force control. In human cadaveric cochleae, robotics-assisted electrode insertion causes less intracochlear trauma compared to manual insertion. Whether this technical advance results in functional benefits in CI patients remains unknown. To address this critical knowledge gap, the investigators will compare cochlear trauma assessed using CT scans, cochlear and AN function assessed using ECochG and/or the eCAP, and clinical outcomes quantified by postoperative residual acoustic hearing and speech perception scores between participants randomized to either manual or robotics-assisted electrode array insertion.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
29mo left

Started Jun 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Jun 2025Aug 2028

First Submitted

Initial submission to the registry

April 15, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 30, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

June 30, 2025

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2028

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2028

Last Updated

July 17, 2025

Status Verified

June 1, 2025

Enrollment Period

2.8 years

First QC Date

April 15, 2025

Last Update Submit

July 15, 2025

Conditions

Keywords

cochlear implantationroboticshearing preservation

Outcome Measures

Primary Outcomes (2)

  • scalar translocation

    Postoperative CT scan will be used to assess scalar translocation

    Postoperative standard of care CT (approximately at activation or 2 weeks)

  • Angular Insertion depth

    Angle of the electrode array inside the cochlea, measured relative to the round window membrane.

    Postoperative standard of care CT (approximately at activation or 2 weeks)

Secondary Outcomes (1)

  • Impedance

    initial activation and at 3 and 6 months post CI

Study Arms (2)

Robot

EXPERIMENTAL

The iotaSOFT™ Insertion System is an FDA approved cochlear implant (CI) electrode array insertion tool. It will be used to assist the surgeon with the cochlear implant insertion.

Device: Robotic

Manual

NO INTERVENTION

Manual cochlear implant surgical procedure without robotic assistance.

Interventions

RoboticDEVICE

The iotaSOFT™ Insertion System is an FDA approved cochlear implant (CI) electrode array insertion tool. It provides surgeons with consistent insertion speed and force. The system consists of a drive unit connected to a touch screen control console and foot pedal interface. The surgeon secures the base to the skull with two pre-loaded self-drilling bone screws. The drive unit is placed into the base and the adjustable drive head is coupled to a CI electrode. Before insertion begins, the surgeon selects the desired speed of insertion. the surgeon controls the electrode insertion forward and reverse motion via foot pedal while guiding the electrode array into the cochlea with standard CI instrumentation. Upon the completion of electrode array insertion, the drive head and unit are uncoupled from the electrode lead and removed from the patient for disposal.

Robot

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Candidate for a cochlear implant according to CMS guidelines
  • Willingness to comply with all study requirements
  • Patent cochlea and normal cochlear anatomy, as confirmed by preoperative imaging
  • English speaking

You may not qualify if:

  • Medical or psychological conditions that contraindicate undergoing surgery
  • Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array.
  • Unrealistic expectations on the part of the candidate and/or candidate's family, regarding the possible benefits, risks, and limitations that are inherent to the surgical procedure(s) and prosthetic devices.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Iowa Healthcare

Iowa City, Iowa, 52242, United States

RECRUITING

Study Officials

  • Bruce Gantz, MD

    University of Iowa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rachel Scheperle, PhD

CONTACT

Camille Dunn, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chair Emeritus, Department of Otolaryngology--Head and Neck Surgery

Study Record Dates

First Submitted

April 15, 2025

First Posted

April 30, 2025

Study Start

June 30, 2025

Primary Completion (Estimated)

March 31, 2028

Study Completion (Estimated)

August 31, 2028

Last Updated

July 17, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Aggregated data will be shared. Individual primary and secondary outcomes are too complex for IPD

Locations